Phase II evaluation of weekly docetaxel in combination with weekly carboplatin in the treatment of recurrent epithelial ovarian carcinoma
Phase of Trial: Phase II
Latest Information Update: 27 Dec 2007
At a glance
- Drugs Carboplatin; Docetaxel
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 27 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 07 Nov 2005 New trial record.